Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

被引:12
|
作者
Alenazi, Aqeel M. [1 ]
Alhowimel, Ahmed S. [1 ]
Alshehri, Mohammed M. [2 ]
Alqahtani, Bader A. [1 ]
Alhwoaimel, Norah A. [1 ]
Segal, Neil A. [3 ]
Kluding, Patricia M. [4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Hlth & Rehabil Sci, Alkharj 11942, Saudi Arabia
[2] Jazan Univ, Dept Phys Therapy, Jazan 45142, Saudi Arabia
[3] Univ Kansas, Dept Phys Med & Rehabil, Med Ctr, Kansas City, KS 66160 USA
[4] Univ Kansas, Dept Phys Therapy & Rehabil Sci, Med Ctr, Kansas City, KS 66160 USA
关键词
osteoarthritis; diabetics; high blood glucose; pain intensity; symptoms; gait; pace; RADIOGRAPHIC KNEE OSTEOARTHRITIS; EARLY POSTOPERATIVE OUTCOMES; CLINICALLY DIAGNOSED KNEE; HAND OSTEOARTHRITIS; RISK-FACTORS; METABOLIC SYNDROME; GENERALIZED OSTEOARTHRITIS; UNITED-STATES; WALKING SPEED; ASSOCIATION;
D O I
10.3390/diagnostics13081386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?
    Ryden, Lars
    Mellbin, Linda
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 690 - 692
  • [2] The Elderly Patient and the ICU: Where Are We Going, Where Should We Go?
    Riou, Bruno
    Boddaert, Jacques
    CRITICAL CARE MEDICINE, 2016, 44 (01) : 231 - +
  • [3] Diversity in gastroenterology in the United States: Where are we now? Where should we go?
    Day, Lukejohn W.
    Gonzalez, Susana
    Ladd, Antonio Mendoza
    Bucobo, Juan Carlos
    Pickett-Blakely, Octavia
    Tilara, Amy
    Christie, Jennifer
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (04) : 679 - 683
  • [4] Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
    Bieber, Thomas
    D'Erme, Angelo M.
    Akdis, Cezmi A.
    Traidl-Hoffmann, Claudia
    Lauener, Roger
    Schappi, Georg
    Schmid-Grendelmeier, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (04) : S58 - S64
  • [5] Behavioral Digital Therapeutics in Gastrointestinal Conditions Where Are We Now and Where Should We Go?
    Greywoode, Ruby
    Szigethy, Eva
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (04) : 741 - 752
  • [6] Colorectal Cancer Control Where Have We Been and Where Should We Go Next?
    Green, Beverly B.
    JAMA INTERNAL MEDICINE, 2018, 178 (12) : 1658 - 1660
  • [7] Eating habits and behaviors of older people: Where are we now and where should we go?
    Yannakoulia, Mary
    Mamalaki, Eirini
    Anastasiou, Costas A.
    Mourtzi, Niki
    Lambrinoudaki, Irene
    Scarmeas, Nikolaos
    MATURITAS, 2018, 114 : 14 - 21
  • [8] Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go
    Gonzalez, Carlos A.
    Agudo, Antonio
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (04) : 745 - 753
  • [9] Alzheimer's disease and infections, where we stand and where we go
    Monastero, Roberto
    Caruso, Calogero
    Vasto, Sonya
    IMMUNITY & AGEING, 2014, 11
  • [10] Sleep, circadian rhythms, and schizophrenia: where we are and where we need to go
    Cosgrave, Jan
    Wulff, Katharina
    Gehrman, Philip
    CURRENT OPINION IN PSYCHIATRY, 2018, 31 (03) : 176 - 182